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Monitoring Postoperative Opioid Use Following
Simple Arthroscopic Meniscectomy
A Performance-Improvement Strategy for Prescribing
Recommendations and Community Safety
Vance Gardner, MD, David Gazzaniga, MD, Michael Shepard, MD, Robert Grumet, MD, Benjamin Rubin, MD,
Michael Dempewolf, DO, Camille Bray, BA, and Carlos Prietto, MD
Investigation performed at Hoag Orthopedics, Irvine, California
Background: Orthopaedic surgeons are confronted with a difficult dilemma: managing acute pain postoperatively and
balancing the risk of prescription opioid use. To our knowledge, a prospective performance-improvement project providing
opioid-prescription recommendations based on the actual amounts of usual and customary medication consumed fol-
lowing simple knee meniscectomy has not been described.
Methods: One hundred and two patients undergoing arthroscopic knee meniscectomy prospectively recorded postop-
erative pain medications in a pain journal. Arthroscopic procedures were performed at 2 centers by 9 fellowship-trained
senior surgeons. Various usual and customary prescribing protocols were observed, and the amount of medication
consumed was recorded. Prescription and over-the-counter pain medication, quantity, frequency, and visual analog scale
(VAS) pain scores were collected.
Results: One hundred and two patients filled a prescription opioid medication and were included in the study. A total of
3,765 pills were prescribed, and a total of 573.5 were consumed. For the 102 patients who filled a prescription, the
average time consuming opioid medication was 2 ± 2 days (range, 0 to 13 days) postoperatively. No cases of persistent
use were recorded. Of the 102 patients who filled a prescription, 29.4% did not take any prescription opioids postoper-
atively. A total of 3,191.5 pills (or 22,183.75 morphine milligram equivalents [MME]) were unused and were potentially
available to the community.
Conclusions: Following simple knee arthroscopy, the amount of prescribed opioid medication exceeds the need for
postoperative pain management. In general, 68% of patients require a maximum of 13 pills postoperatively for 6 days.
Surgeons should adjust prescribing standards accordingly to limit the amount of prescription opioids available to the
community. Furthermore, a comprehensive response to include increased patient screening and monitoring as well as
opioid use and disposal education is recommended.
F
or surgeons treating postoperative pain, a difficult dilemma
has arisen. For years, reports in major publications stated
that acute pain was undertreated and addiction rare1-3 and
institutional stakeholders recommended a more aggressive use
of opioids4,5. Encouraged by breakthroughs in the treatment of
chronic pain and motivated by patient satisfaction surveys
revealing undertreatment of pain6,7, acute-pain services in hos-
pitals began initiating more aggressive postoperative treatment
programs8. Eventually, the treatment of pain as a fifth vital
sign was initiated9 and a subsequent institutional shift of
postoperative pain treatment was promoted7 and conse-
quently mandated10,11.
The resultant decades-long expansion of medical opioid
use in the United States has helped to create an ever-increasing
supply of unused and unmonitored “pain meds” that are available
to the community through postoperative prescriptions12. In ad-
dition, persistent opioid use following minor surgery has been
deemed the most common postoperative surgical complica-
tion13. During this same time period, non-medical use of pre-
scription opioids increased and correlated with amplified use of
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heroin14 and even more dangerous fentanyl medications15.
Simultaneously, unintentional opioid overdoses nearly tripled
from 1997 to 200716 and have become dangerously linked to
non-medical use of opioids17,18. With 7.7% of opioid prescrip-
tions originating from orthopaedic surgeons19, the American
Academy ofOrthopaedic Surgeons responded to this crisis with a
2015 “information statement” recommending the development
of practice-based opioid-prescribing protocols20. However, the
question of how much opioid should be ordered following any
specific surgery remains unresolved.
Orthopaedic surgeons are confronted with the certainty
of creating acute pain with every surgical procedure and opioid
medications have been the mainstay of the compassionate
treatment of postoperative pain for decades. However, the sur-
geon has to weigh 2 rare extremes, namely, that the first surgical
procedure that a patient undergoes theoretically can be the
trigger for either chronic pain21 or opioid abuse22. In addition, a
third risk can affect not only the patient but potentially his or
her family, friends, and community, as 50% of non-medical
users receive their drugs from a friend or relative23. As outpa-
tient procedures require a bulk supply of medications and the
risk of non-medical use is greater than ever, the proper amount
of opioids that should be prescribed for home use remains
unclear. To our knowledge, the relationship between the amount
of pain medication prescribed and the amount consumed
after outpatient surgery has not been studied. An outpatient
performance-improvement project was thought to be the best
method for answering this question. This prospective project
was conducted to evaluate actual opioid use in order to help
determine the proper amount to prescribe following arthro-
scopic meniscectomy. If the results suggested decreasing the
amount of opioids ordered, an additional benefit would be the
possibility that fewer unused opioids would available for non-
medical use in the community. We hypothesized that, following
simple knee arthroscopy, the amount of prescribed opioids
exceeds the amount needed for postoperative painmanagement.
Materials and Methods
Weprospectively monitored the prescription opioid use ofpatients undergoing simple knee meniscectomy through
the use of a patient-recorded, daily pain journal. After approval
from the institutional review board, 500 patients were pro-
jected for enrollment from 9 fellowship-trained sports medi-
cine surgeons at 2 clinical institutions. An interim safety review
of the data was performed after the first 102 patients who
completed the pain journal had ceased using prescription
opioid medication.
The patients were screened by the surgeon preopera-
tively, and an informed-consent process with written consent
was utilized by our research coordinators. The patients were
educated on how to use the pain journal to record their pain
level and medication usage. In addition, they were specifically
instructed to take pain medication as ordered by their surgeon.
Any patient who was solely undergoing arthroscopic menis-
cectomy (medial and/or lateral) was eligible for inclusion. The
exclusion criteria included prior knee surgery, preoperative use
of opioid painmedication, a diagnosis other thanmeniscal tear,
and the use of peripheral nerve block. As per usual and cus-
tomary practice, meniscectomy (either lateral, medial, or both,
with the occasional loose-body removal or debridement) was
performed with use of arthroscopic techniques with the patient
under general anesthesia, and the investigators prescribed their
usual and customary postoperative medication regimen.
Postoperatively, patients were provided with crutches for
walking assistance and were allowed to bear weight and to
proceed to functional recovery as tolerated. Pertinent demo-
graphic and medical information was collected, including age,
sex, race, body mass index (BMI), date of procedure, name of
surgeon, type and dose of local anesthesia used at closure, anti-
inflammatory medication, opioid medication prescribed, amount
of opioid medication used and dates of use, daily pain level as
assessed with a visual analog scale (VAS) (ranging from 1 to 10),
and any over-the-counter medication used.
Patients were called by telephone within the first 72 hours
to remind them to complete the pain journal. Patients were asked
to return the pain journal at their first postoperative visit, usually
7 to 10 days after surgery. Patients still taking prescription opioid
medications were asked to continue tracking their medication
usage. Study procedures concluded when patients returned the
journal and finished using medication for the treatment of
surgical pain. Opioid use and refill requests were recorded and
converted to morphine milligram equivalents (MME24).
No power analysis was performed. The study was designed
as an outpatient performance-improvement project to ascertain
the amount of unused opioids following “usual and customary”
postoperative opioid orders; for this reason, we refer to the par-
ticipants as patients instead of as subjects. We empirically submit-
ted a potential enrollment of 500 patients to the institutional review
board.However, because leftover opioids have been established as a
gateway to opioid abuse and our local county has been seriously
affected25, for community-safety reasons we decided that an
interim data analysis would occur after approximately 100 patients
had filled out the journal. If we discovered a considerable amount
of opioids left over, the community risk would be mitigated by
halting the study and recommending opioid-prescription practice
improvement to the treating physicians.
Results
Study Population
From March 1, 2016, through April 17, 2017, 212 consec-utive patients who underwent simple arthroscopic men-
iscectomy were recruited to record their use of prescribed
postoperative pain medication as well as their daily pain level
with use of a VAS (ranging from 1 to 10). Of these 212 patients,
3 refused a prescription for postoperative opioid medication, 2
were taking narcotics preoperatively, 3 had additional diag-
noses following further work-up, 6 signed the consent after
surgery, and 4 had had prior knee surgery. A total of 194
patients were enrolled. Of these, the 102 patients who filled
their opioid prescriptions and completed the pain journal were
included in the study. The remaining 92 patients did not return
the pain journal and were not included in the final analysis.
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The 102 patients who completed the pain journal included
44 women (43%) and 58 men (57%) who had a mean age of 54
years (range, 19 to 81 years). Eighty-eight patients were Cau-
casian/white (86%), 12 were Hispanic/Caucasian (12%) and 2
were African American (2%) (Table I). An interim data analysis
was performed on these 102 patients. The surprising quantity of
unused opioids potentially available to the community from just
these 102 patients was concerning. This finding prompted a
performance-improvement action plan to mitigate this risk by
halting the study and recommending improved prescription
procedures based on the pain journal data.
Opioids Prescribed
Seventy-seven patients received hydrocodone and acetamino-
phen, 8 received oxycodone and acetaminophen, and 6 received
codeine and acetaminophen as per the standard-of-care pre-
scriptions from their surgeons. In addition, 11 of the 102
patients received a prescription for the synthetic opioid tram-
adol. The total number of opioid pills prescribed was 3,765,
equaling a total MME of 26,967.50. The individual amount of
postoperative medication (as expressed as capsules or pills)
prescribed to each patient ranged from 15 (5 patients) to 60 (10
patients), with a mean of 36.9.
Duration of Opioids Taken
For the 102 patients who filled a prescription, the average time
consuming opioid medication (and standard deviation [SD])
was 2 ± 2 days (range, 0 to 13 days) postoperatively. Conse-
quently, 95% of patients who took opioids postoperatively
consumed their pain medication within the first 6 days after
surgery.
Opioids Taken
Of the 102 patients who filled a prescription, 29 (28.4%) did
not require any medication. For all patients, the mean amount
taken was 6 pills; for those who actually took medication, the
meanwas 8 pills. There was no correlation between the amount
of opioids taken and BMI, VAS score, or consumption of non-
steroidal anti-inflammatory medications. In addition, 83 patients
received some type of local anesthesia at closure but, when
those patients were compared with patients who received no
local anesthesia, there was no correlation between opioid use
and VAS pain score, amount of unused opioids, and amount of
over-the-counter medications taken.
Patients 1 SD above the mean consumed 13 pills, and
patients 2 SDs above the mean consumed 20 pills. Thus, 68% of
the patients consumed £13 pills and 95% of the patients con-
sumed £20 pills. In other words, 95% of patients would only
require 20 opioid pills for the postoperative medication order.
Furthermore, the majority of patients consumed a small per-
centage of the opioids from the prescriptions that they filled.
Medication Left Over from the Entire Population
Overall, only 573.5 opioid pills were consumed, leaving 3,191.5
pills left over. It is not clear how and if patients discarded excess
medication appropriately, but since proper disposal was not
part of any preoperative education process, we doubt that many
pills were discarded. Therefore, potentially 22,183.75 MME of
prescribed opioids were made available for non-medical use
following 102 arthroscopic procedures.
Discussion
Orthopaedic surgeons are becoming aware that postoper-ative opioid treatment is fraught with challenges and that
reforms to postoperative prescribing protocols are needed. It
was recently revealed that a 1-paragraph letter to The New
England Journal of Medicine in 1980 may have sparked the
overcoverage of acute pain by arguing that hospital-based
opioids offer minimal chance of addiction26. The medical
community now recognizes that this conclusion was not cor-
rect. In June 2016, the American Medical Association (AMA)
voted to remove pain as the “fifth vital sign” because of con-
cerns that this long-heralded approach may have unwittingly
contributed to the opioid crisis in America, with the AMA
president stating that physicians were part of the problem by
overprescribing and should now be part of the solution27.
Because of the nature of their work, orthopaedic sur-
geons are on the front line of postoperative pain management,
and opioids are commonly prescribed after orthopaedic pro-
cedures. Individual requirements can be modified depending
on patient needs, risks, and past usage, but evidence-based
guidelines for various surgical procedures are not readily
obtainable. The compassionate treatment of postoperative pain
TABLE I Demographic Characteristics
Characteristic
No. of Patients
(N = 102)
Sex
Male 58 (57%)
Female 44 (43%)
Age, per decade
<21yr 1 (1.0%)
21-30 yr 6 (5.9%)
31-40 yr 7 (6.9%)
41-50 yr 18 (17.6%)
51-60 yr 36 (35.3%)
61-70 yr 29 (28.4%)
71-80 yr 4 (3.9%)
81-90 yr 1 (1.0%)
Race
African American 2 (2%)
Caucasian/white 88 (86%)
Hispanic 12 (12%)
BMI
Underweight (18.3 kg/m2) 1 (1%)
Normal or healthy weight (18.7-24.9 kg/m2) 24 (23.5%)
Overweight (25.0-29.9 kg/m2) 44 (43.1%)
Obese (30.0-53.2 kg/m2) 33 (32.4%)
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with opioids is essential to good health care. However, recent
reports have demonstrated that postoperative opioids can be
misused in 2 ways. First, appropriate medications prescribed
for postoperative pain can be abused by a small percentage of
patients, and persistent opioid use by first-time users has been
documented28,29. Second, unused opioids can be diverted into
the hands of family, friends, or unknown users. This popula-
tion is a growing factor in the opioid crisis30.
Our analysis focuses on the latter, as the postoperative
use of opioids by patients who had undergone simple arthro-
scopic meniscectomy was surprisingly low. However, the
amount of unused opioids was startlingly high and, because of
the risk to the community, we decided to halt the project and
recommended that the practices develop improved prescrip-
tion procedures.
We found that most patients who used the medications
did so only through the first week after surgery. Conse-
quently, almost all patients had finished taking prescription
opioid medication by the time of the first postoperative visit,
within 10 days. Furthermore, our analysis demonstrated that
it is safe and effective to prescribe 13 opioid pills to meet the
needs of 68% of patients who have undergone arthroscopic
meniscectomy.
Instead of revealing persistent use of opioids, as has been
shown in studies of total knee arthroplasty28, our data on 102
arthroscopic meniscectomies revealed a substantial amount of
leftover medication, with >3,000 new opioid pills (or 22,183.75
MME) being available for non-medical use if proper disposal
was not performed by the patient. A recent systematic review of
7 clinical trials with available data on opioid use demonstrated
that two-thirds of patients reported unused opioids following
surgery31. The authors stated that most patients stored unused
opioids in unlocked medicine cabinets and recommended a
“data driven response” instead of “one size fits all” approach,
with education being needed to instruct patients on the proper
disposal of opioids and “take back” events. In addition, risk
factors need to be identified preoperatively32,33. Physician re-
sources in California include the CURES (Controlled Sub-
stance Utilization Review and Evaluation System) web site that
can help to detect persistent use and is helpful for monitoring
outliers25. Overprescribed opioid medication following simple
orthopaedic procedures may lead to negative consequences in
the community. Opioid-related drug overdoses in the U.S.
numbered 33,091 in 2015, with one-half involving prescription
opioids34. Sabatino et al., in a 2018 retrospective chart review
with patient call-back, studied the variation in opioid pre-
scriptions for 5 common orthopaedic procedures in a northern
New England practice. The authors found that unused opioids
remained after postoperative pain management and recom-
mended prescribing slightly less than the median value30.
However, it is unclear if that institution implemented changes
to the practice on the basis of those findings. We are unaware of
any investigators who have prospectively measured how much
opioid medication is actually consumed following arthroscopic
meniscectomy and then used that information to provide
positive change in the local practice and community.
The present study had some limitations. First, 92
patients did not return the pain journal, and only 102 compliant
patients were studied. However, the discovery of so many
leftover opioids following these procedures warranted halting
the study, recommending improved prescribing practices,
and reporting our results. Second, we also recognize the
potential weakness of different prescribing patterns. However,
our goal was to observe the usual and customary practice of 9
surgeons and not to recommend a standard postoperative
prescription until we had completed our interim study
analysis. Finally, even though we were dependent on pa-
tients to record their pill use prospectively, which required
trust in their record-keeping, this method minimized recall
bias that would have occurred from a retrospective “call-back”
protocol.
Because of the reality of the public health crisis in our
community35, we were concerned with our findings. In the
patient population studied, we believe that 13 opioid pills
(slightly more than 1 SD above the mean) are adequate for
postoperative pain control following simple arthroscopic knee
surgery.
Our institution is in the process of creating a response to
the growing crisis of unused opioids for the safety of our patients
and the general public. This response has 5 areas of focus:
(1) Physician education about the proper amount of opioid
pills for arthroscopic meniscectomy and the develop-
ment of a Postoperative Pain Management Protocol
following arthroscopic surgery. We plan on developing
this type of protocol for all surgical categories (including
anterior cruciate ligament [ACL], arthroplasty, spine,
foot, and hand).
(2) Improved patient screening for risk factors for opioid
dependence.
(3) Patient education about the addiction potential of post-
operative opioids.
(4) Greater monitoring of opioid use.
(5) Patient education about proper disposal.
The participating investigators are in the early stages
of implementing these system-wide practice changes. Hoag
Orthopedics plans on reporting the outcome in a later publi-
cation. In addition, the performance-improvement process is
continuing with pain journal reports for total knee arthro-
plasty, rotator cuff repair, and ACL reconstruction.
The overprescription of opioid medication can create
negative effects in the community caused by non-medical
consumption and abuse. Thirteen pills of prescription opioid
medication should be sufficient for postoperative pain man-
agement following an uncomplicated arthroscopic knee men-
iscectomy, and non-opioid alternatives should be considered.
Positive changes to preoperative screening, prescribing practice,
patient education, and proper disposal are needed. Moreover,
additional studies that elucidate proper dosing for other
common procedures of orthopaedic and other medical special-
ties are essential to address the current opioid epidemic. n
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